GCTK

SEC source: 0001474506-25-000073 · primary_doc.xml · derivative · entry 3

John A. Ballantyne Revocable Living Trust dated 08/01/2017 · CIK 0002046615 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,667

Underlying: Common Stock, par value $0.001 per share · 106,667 shares

Expires 2034-07-30

F1 · kind: On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the "Warrants") with the John A. Ballantyne Rev Trust 08/01/2017 (the "Ballantyne Trust"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the "Note"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the "Common Stock").

F2 · kind: On November 14, 2024, the issuer completed a public offering (the "Offering"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the "Series A Common Warrants") and 132,036 accompanying Series B common warrants (the "Series B Common Warrants")), based on a conversion price of $31.00 per share (the "Conversion"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed.

F1 · price: On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the "Warrants") with the John A. Ballantyne Rev Trust 08/01/2017 (the "Ballantyne Trust"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the "Note"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the "Common Stock").

F2 · price: On November 14, 2024, the issuer completed a public offering (the "Offering"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the "Series A Common Warrants") and 132,036 accompanying Series B common warrants (the "Series B Common Warrants")), based on a conversion price of $31.00 per share (the "Conversion"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed.

SEC source: 0001474506-25-000072 · primary_doc.xml · derivative · entry 6

BALLANTYNE JOHN · CIK 0001701346 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · John A. Ballantyne Rev Trust 08/01/2017

Disclosed balance after: 59,260

Underlying: Common Stock, par value $0.001 per share · 59,260 shares

Expires 2034-07-30

F1 · kind: On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the "Warrants") with the John A. Ballantyne Rev Trust 08/01/2017 (the "Ballantyne Trust"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the "Note"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the "Common Stock").

F2 · kind: On November 14, 2024, the issuer completed a public offering (the "Offering"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the "Series A Common Warrants") and 132,036 accompanying Series B common warrants (the "Series B Common Warrants")), based on a conversion price of $31.00 per share (the "Conversion"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed.

F1 · price: On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the "Warrants") with the John A. Ballantyne Rev Trust 08/01/2017 (the "Ballantyne Trust"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the "Note"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the "Common Stock").

F2 · price: On November 14, 2024, the issuer completed a public offering (the "Offering"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the "Series A Common Warrants") and 132,036 accompanying Series B common warrants (the "Series B Common Warrants")), based on a conversion price of $31.00 per share (the "Conversion"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed.

F3 · ownership.direct: John A. Ballantyne is the trustee of the Ballantyne Trust and has sole voting and investment power over all securities owned by the Ballantyne Trust.

SEC source: 0001474506-25-000072 · primary_doc.xml · derivative · entry 5

BALLANTYNE JOHN · CIK 0001701346 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · John A. Ballantyne Rev Trust 08/01/2017

Disclosed balance after: 76,191

Underlying: Common Stock, par value $0.001 per share · 76,191 shares

Expires 2034-07-30

F1 · kind: On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the "Warrants") with the John A. Ballantyne Rev Trust 08/01/2017 (the "Ballantyne Trust"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the "Note"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the "Common Stock").

F2 · kind: On November 14, 2024, the issuer completed a public offering (the "Offering"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the "Series A Common Warrants") and 132,036 accompanying Series B common warrants (the "Series B Common Warrants")), based on a conversion price of $31.00 per share (the "Conversion"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed.

F1 · price: On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the "Warrants") with the John A. Ballantyne Rev Trust 08/01/2017 (the "Ballantyne Trust"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the "Note"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the "Common Stock").

F2 · price: On November 14, 2024, the issuer completed a public offering (the "Offering"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the "Series A Common Warrants") and 132,036 accompanying Series B common warrants (the "Series B Common Warrants")), based on a conversion price of $31.00 per share (the "Conversion"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed.

F3 · ownership.direct: John A. Ballantyne is the trustee of the Ballantyne Trust and has sole voting and investment power over all securities owned by the Ballantyne Trust.

SEC source: 0001474506-25-000072 · primary_doc.xml · derivative · entry 4

BALLANTYNE JOHN · CIK 0001701346 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · John A. Ballantyne Rev Trust 08/01/2017

Disclosed balance after: 106,667

Underlying: Common Stock, par value $0.001 per share · 106,667 shares

Expires 2034-07-30

F1 · kind: On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the "Warrants") with the John A. Ballantyne Rev Trust 08/01/2017 (the "Ballantyne Trust"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the "Note"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the "Common Stock").

F2 · kind: On November 14, 2024, the issuer completed a public offering (the "Offering"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the "Series A Common Warrants") and 132,036 accompanying Series B common warrants (the "Series B Common Warrants")), based on a conversion price of $31.00 per share (the "Conversion"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed.

F1 · price: On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the "Warrants") with the John A. Ballantyne Rev Trust 08/01/2017 (the "Ballantyne Trust"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the "Note"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the "Common Stock").

F2 · price: On November 14, 2024, the issuer completed a public offering (the "Offering"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the "Series A Common Warrants") and 132,036 accompanying Series B common warrants (the "Series B Common Warrants")), based on a conversion price of $31.00 per share (the "Conversion"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed.

F3 · ownership.direct: John A. Ballantyne is the trustee of the Ballantyne Trust and has sole voting and investment power over all securities owned by the Ballantyne Trust.

SEC source: 0001474506-25-000069 · primary_doc.xml · derivative · entry 6

Goode Paul · CIK 0001622251 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock, par value $0.001 per share · 321 shares

Expires not disclosed

F3 · derivative.exercise_date: On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $10,000 (the "Note"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the "Maturity Date").

F4 · derivative.exercise_date: If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the "Note Balance"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a "Qualified Financing"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the "Floor Price").

F3 · derivative.expiration_date: On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $10,000 (the "Note"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the "Maturity Date").

F4 · derivative.expiration_date: If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the "Note Balance"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a "Qualified Financing"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the "Floor Price").

SEC source: 0001474506-25-000070 · primary_doc.xml · derivative · entry 6

Carter Erin Catherine · CIK 0001993078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock, par value $0.001 per share · 1,603 shares

Expires not disclosed

F1 · derivative.exercise_date: On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $50,000 (the "Note"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the "Maturity Date").

F2 · derivative.exercise_date: If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the "Note Balance"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a "Qualified Financing"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the "Floor Price").

F1 · derivative.expiration_date: On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $50,000 (the "Note"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the "Maturity Date").

F2 · derivative.expiration_date: If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the "Note Balance"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a "Qualified Financing"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the "Floor Price").

SEC source: 0001474506-25-000071 · primary_doc.xml · derivative · entry 13

Malave Luis · CIK 0001395781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock, par value $0.001 per share · 6,411 shares

Expires not disclosed

F1 · derivative.exercise_date: On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $200,000 (the "Note"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the "Maturity Date").

F2 · derivative.exercise_date: If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the "Note Balance"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a "Qualified Financing"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the "Floor Price").

F1 · derivative.expiration_date: On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $200,000 (the "Note"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the "Maturity Date").

F2 · derivative.expiration_date: If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the "Note Balance"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a "Qualified Financing"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the "Floor Price").

SEC source: 0001474506-24-000178 · primary_doc.xml · derivative · entry 1

SYCOFF DREW · CIK 0001083139 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,000

Underlying: Common Stock · 138,000 shares

Expires 2029-07-01

F1 · kind: On July 1, 2024, pursuant to a private placement offering by the Issuer, the Reporting Person acquired warrants to purchase 138,000 shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock") for an aggregate purchase price of $46,000. Each warrant entitles the holder thereof to purchase one share of Common Stock, is immediately exercisable from the date of issuance at an exercise price of $4.95 per share, and expires five years after issuance.

F1 · price: On July 1, 2024, pursuant to a private placement offering by the Issuer, the Reporting Person acquired warrants to purchase 138,000 shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock") for an aggregate purchase price of $46,000. Each warrant entitles the holder thereof to purchase one share of Common Stock, is immediately exercisable from the date of issuance at an exercise price of $4.95 per share, and expires five years after issuance.

SEC source: 0001474506-24-000177 · primary_doc.xml · derivative · entry 1

Goode Paul · CIK 0001622251 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,000

Underlying: Common Stock · 42,000 shares

Expires 2029-07-01

F1 · kind: On July 1, 2024, pursuant to a private placement offering by the Issuer, the Reporting Person acquired warrants to purchase 42,000 shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock") for an aggregate purchase price of $14,000. Each warrant entitles the holder thereof to purchase one share of Common Stock, is immediately exercisable from the date of issuance at an exercise price of $4.95 per share, and expires five years after issuance.

F1 · price: On July 1, 2024, pursuant to a private placement offering by the Issuer, the Reporting Person acquired warrants to purchase 42,000 shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock") for an aggregate purchase price of $14,000. Each warrant entitles the holder thereof to purchase one share of Common Stock, is immediately exercisable from the date of issuance at an exercise price of $4.95 per share, and expires five years after issuance.

SEC source: 0001474506-25-000069 · primary_doc.xml · derivative · entry 5

Goode Paul · CIK 0001622251 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,100

Underlying: Common Stock, par value $0.001 per share · 2,100 shares

Expires 2029-07-01

F2 · price: On July 1, 2025, the reporting person purchased a promissory note in the principal amount of $14,000 and an accompanying warrant to purchase shares of common stock, par value $0.001 per share (the "Common Stock") at an exercise price of $99.00 per share.

SEC source: 0001474506-25-000069 · primary_doc.xml · derivative · entry 4

Goode Paul · CIK 0001622251 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,277

Underlying: Common Stock, par value $0.001 per share · 3,277 shares

Expires 2034-06-14

F1 · derivative.exercise_date: This stock option award is 100% vested.

SEC source: 0001493152-24-015833 · ownership.xml · nonDerivative · entry 1

SYCOFF DREW · CIK 0001083139 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,951,257.6

F1 · balance_after: In addition to the purchase reported above, ownership includes: (i) 76,279 shares of common stock owned by Mr. Sycoff; and (ii) 116,501 common stock owned by Andrew Garrett, Inc. Mr. Sycoff has voting power and investment control over the shares of common stock held by Andrew Garrett, Inc. Alma Diversified Holdings LLC, an entity owned by Sharon Sycoff, the wife of Mr. Sycoff owns 2,575,938 shares of common stock. Sharon Sycoff has voting power and investment control over the shares held by Alma Diversified Holdings LLC and Mr. Sycoff disclaims beneficial ownership in the shares held by Alma Diversified Holdings LLC.

SEC source: 0001474506-25-000068 · primary_doc.xml · nonDerivative · entry 2

Danzig Allen · CIK 0001905433 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 424

SEC source: 0001474506-25-000066 · primary_doc.xml · nonDerivative · entry 2

Fischell Robert · CIK 0001557104 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 547

SEC source: 0001474506-25-000070 · primary_doc.xml · nonDerivative · entry 2

Carter Erin Catherine · CIK 0001993078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,361

SEC source: 0001474506-25-000071 · primary_doc.xml · nonDerivative · entry 9

Malave Luis · CIK 0001395781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,123

SEC source: 0001474506-25-000070 · primary_doc.xml · nonDerivative · entry 1

Carter Erin Catherine · CIK 0001993078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 903

SEC source: 0001474506-25-000071 · primary_doc.xml · nonDerivative · entry 8

Malave Luis · CIK 0001395781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 634

SEC source: 0001474506-25-000071 · primary_doc.xml · nonDerivative · entry 7

Malave Luis · CIK 0001395781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272

SEC source: 0001474506-25-000071 · primary_doc.xml · nonDerivative · entry 6

Malave Luis · CIK 0001395781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151

SEC source: 0001474506-25-000068 · primary_doc.xml · nonDerivative · entry 1

Danzig Allen · CIK 0001905433 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195

SEC source: 0001474506-25-000071 · primary_doc.xml · nonDerivative · entry 5

Malave Luis · CIK 0001395781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122

SEC source: 0001474506-25-000071 · primary_doc.xml · nonDerivative · entry 4

Malave Luis · CIK 0001395781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78

SEC source: 0001474506-25-000071 · primary_doc.xml · nonDerivative · entry 3

Malave Luis · CIK 0001395781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44

SEC source: 0001474506-25-000071 · primary_doc.xml · nonDerivative · entry 2

Malave Luis · CIK 0001395781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19

SEC source: 0001474506-25-000071 · primary_doc.xml · nonDerivative · entry 1

Malave Luis · CIK 0001395781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8

SEC source: 0001474506-25-000066 · primary_doc.xml · nonDerivative · entry 1

Fischell Robert · CIK 0001557104 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 318

SEC source: 0001178913-17-001954 · zk1720207.xml · derivative · entry 1

podwalski david · CIK 0001707814 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,585

Underlying: Common Stock, par value $0.001 per share · 290,585 shares

Expires 2027-06-26

F1 · derivative.exercise_date: The options will vest in equal monthly installments over a three year period commencing on June 26, 2017.

SEC source: 0001178913-17-001725 · zk1720093.xml · derivative · entry 2

SCHWARTZ REVAN · CIK 0001690043 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,727

Underlying: Common Stock, par value $0.001 per share · 22,727 shares

Expires not disclosed

F2 · derivative.exercise_date: The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date.

F3 · derivative.expiration_date: The common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer.

SEC source: 0001178913-17-001725 · zk1720093.xml · derivative · entry 1

SCHWARTZ REVAN · CIK 0001690043 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,894

Underlying: Common Stock, par value $0.001 per share · 14,894 shares

Expires 2027-06-01

F1 · derivative.exercise_date: The options will vest in equal monthly installments over a one year period commencing on June 1, 2017.

SEC source: 0001178913-17-001727 · zk1720094.xml · derivative · entry 2

Seff Leslie · CIK 0001670027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,727

Underlying: Common Stock, par value $0.001 per share · 22,727 shares

Expires not disclosed

F2 · derivative.exercise_date: The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date.

F3 · derivative.expiration_date: The common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer.

SEC source: 0001178913-17-001727 · zk1720094.xml · derivative · entry 1

Seff Leslie · CIK 0001670027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,894

Underlying: Common Stock, par value $0.001 per share · 14,894 shares

Expires 2027-06-01

F1 · derivative.exercise_date: The options will vest in equal monthly installments over a one year period commencing on June 1, 2017.

SEC source: 0001178913-17-001759 · zk1720102.xml · derivative · entry 2

BOYDSTON ANGELA STRAND · CIK 0001299164 · Director · Interim Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,252

Underlying: Common Stock, par value $0.001 per share · 25,252 shares

Expires not disclosed

F2 · derivative.exercise_date: The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date.

F3 · derivative.expiration_date: After June 1, 2018, the common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer.

SEC source: 0001178913-17-001759 · zk1720102.xml · derivative · entry 1

BOYDSTON ANGELA STRAND · CIK 0001299164 · Director · Interim Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,894

Underlying: Common Stock, par value $0.001 per share · 14,894 shares

Expires 2027-06-01

F1 · derivative.exercise_date: The options will vest in equal monthly installments over a one year period commencing on June 1, 2017.

SEC source: 0001178913-17-001757 · zk1720103.xml · derivative · entry 2

Fischell Robert · CIK 0001557104 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,727

Underlying: Common Stock, par value $0.001 per share · 22,727 shares

Expires not disclosed

F2 · derivative.exercise_date: The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date.

F3 · derivative.expiration_date: The common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer.

SEC source: 0001178913-17-001757 · zk1720103.xml · derivative · entry 1

Fischell Robert · CIK 0001557104 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,894

Underlying: Common Stock, par value $0.001 per share · 14,894 shares

Expires 2027-06-01

F1 · derivative.exercise_date: The options will vest in equal monthly installments over a one year period commencing on June 1, 2017.

SEC source: 0001178913-17-001782 · a1720119.xml · derivative · entry 1

SCHWARTZ REVAN · CIK 0001690043 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,727

Underlying: Common Stock, par value $0.001 per share · 22,727 shares

Expires not disclosed

F1 · derivative.exercise_price: The restricted stock units do not have a conversion or exercise price. The reporting person's original Form 4 included a conversion price of $1.98.

F2 · derivative.exercise_date: The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date.

F3 · derivative.expiration_date: After June 1, 2018, the common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer.

SEC source: 0001178913-17-001780 · zk1720118.xml · derivative · entry 1

Seff Leslie · CIK 0001670027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,727

Underlying: Common Stock, par value $0.001 per share · 22,727 shares

Expires not disclosed

F1 · derivative.exercise_price: The restricted stock units do not have a conversion or exercise price. The reporting person's original Form 4 included a conversion price of $1.98.

F2 · derivative.exercise_date: The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date.

F3 · derivative.expiration_date: After June 1, 2018, the common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer.

SEC source: 0001178913-17-001788 · zk1720121.xml · derivative · entry 1

Fischell Robert · CIK 0001557104 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,727

Underlying: Common Stock, par value $0.001 per share · 22,727 shares

Expires not disclosed

F1 · derivative.exercise_price: The restricted stock units do not have a conversion or exercise price. The reporting person's original Form 4 included a conversion price of $1.98.

F2 · derivative.exercise_date: The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date.

F3 · derivative.expiration_date: After June 1, 2018, the common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer.

SEC source: 0001178913-17-001784 · zk1720120.xml · derivative · entry 2

Hauck Michael · CIK 0001708854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,727

Underlying: Common Stock, par value $0.001 per share · 22,727 shares

Expires not disclosed

F2 · derivative.exercise_date: The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date.

F3 · derivative.expiration_date: After June 1, 2018, the common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer.

SEC source: 0001178913-17-001784 · zk1720120.xml · derivative · entry 1

Hauck Michael · CIK 0001708854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,894

Underlying: Common Stock, par value $0.001 per share · 14,894 shares

Expires 2027-06-01

F1 · derivative.exercise_date: The options will vest in equal monthly installments over a one year period commencing on June 1, 2017.

SEC source: 0001178913-17-001121 · zk1719817.xml · derivative · entry 3

Malka David · CIK 0001556758 · Vice President of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock, par value $0.001 per share · 25,000 shares

Expires not disclosed

F4 · kind: Pursuant to the employment agreement entered into by the Company's wholly owned subsidiary, A.D. Integrity Applications Ltd. and the Reporting Person, the grant of the options to purchase common stock is subject to the Company reaching certain corporate development milestones.

F5 · derivative.exercise_date: The option shall vest over a three year period beginning on the date of grant as set forth in Note 4.

F6 · derivative.expiration_date: The option shall expire upon the ten (10) year anniversary of the date of grant as set forth in Note 4.

SEC source: 0001178913-17-001121 · zk1719817.xml · derivative · entry 2

Malka David · CIK 0001556758 · Vice President of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,617

Underlying: Common Stock, par value $0.001 per share · 266,617 shares

Expires 2027-04-13

F3 · derivative.exercise_date: The option shall vest 50% upon CFDA approval and 50% upon FDA approval.

SEC source: 0001178913-17-001121 · zk1719817.xml · derivative · entry 1

Malka David · CIK 0001556758 · Vice President of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 361,875

Underlying: Common Stock, par value $0.001 per share · 361,875 shares

Expires 2027-04-13

F1 · shares: On a fully diluted basis.

F2 · derivative.exercise_date: The options shall vest over a three-year period commencing on April 13, 2017.

F1 · derivative.underlying_shares: On a fully diluted basis.

SEC source: 0001178913-17-000849 · zk1719710.xml · nonDerivative · entry 1

Seff Leslie · CIK 0001670027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,334

F1 · kind: Transferred to the Reporting Person by the Issuer in consideration of the Reporting Person's performance of certain consulting services.

SEC source: 0001178913-17-000851 · zk1719711.xml · nonDerivative · entry 2

BOYDSTON ANGELA STRAND · CIK 0001299164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,445

F3 · shares: Granted as restricted common stock, which will vest in equal monthly installments over a one year period commencing on March 20, 2017.

SEC source: 0001178913-17-000851 · zk1719711.xml · nonDerivative · entry 1

BOYDSTON ANGELA STRAND · CIK 0001299164 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Strand Strategy

Disclosed balance after: 13,334

F1 · kind: Transferred to Strand Strategy by the Issuer pursuant to a Consulting Agreement, effective December 1, 2017, by and between the Issuer and Strand Strategy (the "Agreement"). Pursuant to the Agreement and the transactions contemplated thereby, and in consideration of Strand Strategy's performance of certain services under the Agreement, on March 20, 2017, the Board of Directors of the Issuer authorized the issuance of 13,334 shares of common stock, par value $0.001 per share, of the Issuer, to Strand Strategy. The Agreement indicates that such issuance is based on a $4.50 per share valuation.

F1 · price: Transferred to Strand Strategy by the Issuer pursuant to a Consulting Agreement, effective December 1, 2017, by and between the Issuer and Strand Strategy (the "Agreement"). Pursuant to the Agreement and the transactions contemplated thereby, and in consideration of Strand Strategy's performance of certain services under the Agreement, on March 20, 2017, the Board of Directors of the Issuer authorized the issuance of 13,334 shares of common stock, par value $0.001 per share, of the Issuer, to Strand Strategy. The Agreement indicates that such issuance is based on a $4.50 per share valuation.

F2 · ownership.nature: The securities are held by Strand Strategy, of which the Reporting Person is the managing director. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001178913-17-000855 · zk1719718.xml · derivative · entry 3

GRAHAM JOHN A · CIK 0001701726 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 844,130

Underlying: Common Stock, par value $0.001 per share · 844,130 shares

Expires 2027-03-20

F1 · derivative.exercise_date: The options will vest in equal monthly installments over a three year period commencing on March 20, 2017.

SEC source: 0001178913-17-000855 · zk1719718.xml · derivative · entry 2

GRAHAM JOHN A · CIK 0001701726 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 559,414

Underlying: Common Stock, par value $0.001 per share · 559,414 shares

Expires 2027-03-20

F1 · derivative.exercise_date: The options will vest in equal monthly installments over a three year period commencing on March 20, 2017.

SEC source: 0001178913-17-000855 · zk1719718.xml · derivative · entry 1

GRAHAM JOHN A · CIK 0001701726 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,673,996

Underlying: Common Stock, par value $0.001 per share · 1,673,996 shares

Expires 2027-03-20

F1 · derivative.exercise_date: The options will vest in equal monthly installments over a three year period commencing on March 20, 2017.